跳至主要内容
临床试验/NCT04078282
NCT04078282已完成不适用

The Use of Collaborative Care in General Practice for Elderly Patients With Depression

University of Oslo1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2019年9月15日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
30
试验地点
1
主要终点
Number of patients with a change in clinical significant depression

研究概览

简要总结

The first part of this study aims to identify the occurence of depression in the elderly. In the second part, older patients with depression will be invited to a collaborative care with his or her family physician and a psychiatrist specialized in psychiatry in the elderly in accordance with a study protocol. The intervention includes two sessions where the patient will meet the psychiatrist together with the family physician, and between the two sessions the patient will have three treatment sessions with the family physician based on the evaluation by the psychiatrist. Following the last session with the psychiatrist the intervention ends with three more treatment sessions with the family physician.

详细描述

The frequency of depression in the elderly is little known and experiences from family practice indicate that older people not always communicate their mental health issues or present physical complaints which may arise from a state of depression. In this study we aim to register the occurence of depression among all patients at the age of 65 or older who visit their family physician. During a period of four weeks, all patients meeting the eligibility criteria will be asked to answer a questionnaire about mental and physic health issues. Those who respond in a manner that gives reasons to believe there is a depression will be contacted by their family physician to meet for a consultation and examination. If this examination confirms the diagnosis the patient will either be treated as usual by their family physician (control group) or be invited to a collaborative care with the family physician in cooperation with a psychiatrist who is specialized in psychiatry in the elderly (intervention group). In the control group the patients will receive usual care at their family physician or be referred to a psychiatrist or a psychologist if appropriate. In the intervention group the patients will have a evaluation session with the family physician and the psychiatrist together. Following this session, the patient and the family physician will meet for three treatment consultations based on the evaluation and recommendations given by the psychiatrist. Then there will be one more joint session with the patient, the family physician and the psychiatrist and the whole treatment program ends with three more treatment consultations at the family physician. - The aim of this intervention is to examine whether this treatment program is more or equally efficient to treat depression in the elderly as usual care and at lower cost and use of specialized care.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
65 Years 至 —(Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •all patients visiting one of the collaborative family physicians during the enrollment period of four weeks

排除标准

  • •cognitive dysfunction
  • •speaking Norwegian language

研究组 & 干预措施

Active treatment group

Experimental

Patients will meet in a joint consultation with their family physician and a psychiatrist for evaluation. Then it follows three treatment sessions with the family physician before a new joint consultation with the psychiatrist. The intervention ends with three more treatment sessions with the family physician.

干预措施: Intervention group (Behavioral)

Control group

Active Comparator

Patients belonging to family physicians who constitute the control group will be assessed and given treatment according to usual care. This may include treatment by the family physician, medication, referrals to specialized care.

干预措施: Intervention group (Behavioral)

结局指标

主要结局

Number of patients with a change in clinical significant depression

时间窗: At start and at 12 and 18 month following treatment

Change in depression as described by the Patient Health Questionnaire (PHQ-9). The questionnaire is a 9-item questionnaire, each with a 0-4 point scale. A change of 3,9 points in the sumscale is regarded significant.

次要结局

  • Number of patients with a change in the level of anxiety(At start and at 12 and 18 month following treatment)
  • Number of Subjective Health Complaints among patients with depression(At start and at 12 and 18 month following treatment)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Erik L Werner

Professor

University of Oslo

研究点 (1)

Loading locations...

相似试验